Nisa Investment Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615 | Buy |
430
+267
| +164% | +$382 | ﹤0.01% | 2836 |
|
|
2025
Q1 | $261 | Buy |
+163
| New | +$261 | ﹤0.01% | 2893 |
|
|
2024
Q4 | – | Sell |
-165
| Closed | -$941 | – | 3011 |
|
|
2024
Q3 | $941 | Buy |
+165
| New | +$941 | ﹤0.01% | 2593 |
|
|
2023
Q4 | – | Sell |
-490
| Closed | -$911 | – | 2660 |
|
|
2023
Q3 | $911 | Sell |
490
-32
| -6% | -$59 | ﹤0.01% | 2410 |
|
|
2023
Q2 | $1.44K | Sell |
522
-6
| -1% | -$17 | ﹤0.01% | 2388 |
|
|
2023
Q1 | $2K | Sell |
528
-2,562
| -83% | -$9.71K | ﹤0.01% | 2313 |
|
|
2022
Q4 | $18K | Hold |
3,090
| – | – | ﹤0.01% | 2080 |
|
|
2022
Q3 | $30K | Hold |
3,090
| – | – | ﹤0.01% | 1930 |
|
|
2022
Q2 | $23K | Buy |
3,090
+2,600
| +531% | +$19.4K | ﹤0.01% | 2007 |
|
|
2022
Q1 | $12K | Sell |
490
-1,130
| -70% | -$27.7K | ﹤0.01% | 2162 |
|
|
2021
Q4 | $40K | Buy |
1,620
+930
| +135% | +$23K | ﹤0.01% | 1784 |
|
|
2021
Q3 | $31 | Hold |
690
| – | – | ﹤0.01% | 2012 |
|
|
2021
Q2 | $26 | Buy |
+690
| New | +$26 | ﹤0.01% | 2081 |
|